phosphatidylcholines has been researched along with miconazole in 7 studies
Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (miconazole) | Trials (miconazole) | Recent Studies (post-2010) (miconazole) |
---|---|---|---|---|---|
32,204 | 443 | 5,593 | 2,309 | 238 | 476 |
Protein | Taxonomy | phosphatidylcholines (IC50) | miconazole (IC50) |
---|---|---|---|
Metabotropic glutamate receptor 6 | Homo sapiens (human) | 6.5 | |
Acetylcholinesterase | Electrophorus electricus (electric eel) | 2.4 | |
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 5.314 | |
Bile salt export pump | Homo sapiens (human) | 10 | |
Cytochrome P450 1A2 | Mus musculus (house mouse) | 4.55 | |
Cytochrome P450 1A2 | Rattus norvegicus (Norway rat) | 4.55 | |
Cytochrome P450 1A2 | Homo sapiens (human) | 4.55 | |
Tyrosine-protein kinase Fyn | Homo sapiens (human) | 4.16 | |
Heme oxygenase 1 | Rattus norvegicus (Norway rat) | 5.8 | |
ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 2 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 2.939 | |
Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 4.336 | |
Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 3.197 | |
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 3 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.4938 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 3.966 | |
Adenosine receptor A3 | Homo sapiens (human) | 2.811 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 1.32 | |
Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 3.971 | |
Aromatase | Homo sapiens (human) | 0.6 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 0.2 | |
Beta-3 adrenergic receptor | Homo sapiens (human) | 5.482 | |
Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | 3.7 | |
Androgen receptor | Rattus norvegicus (Norway rat) | 7.089 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 2.811 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 3.598 | |
Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 3.154 | |
ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 7.8 | |
Substance-K receptor | Homo sapiens (human) | 4.839 | |
D(1A) dopamine receptor | Homo sapiens (human) | 6.247 | |
Heme oxygenase 2 | Rattus norvegicus (Norway rat) | 5.8 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2.939 | |
Thromboxane-A synthase | Homo sapiens (human) | 0.263 | |
Histamine H2 receptor | Homo sapiens (human) | 6.75 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 3.046 | |
Substance-P receptor | Homo sapiens (human) | 6.813 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 3.907 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 5.314 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.778 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 0.008 | |
Mu-type opioid receptor | Homo sapiens (human) | 6.059 | |
D(3) dopamine receptor | Homo sapiens (human) | 3.199 | |
Delta-type opioid receptor | Homo sapiens (human) | 3.387 | |
Kappa-type opioid receptor | Homo sapiens (human) | 6.594 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 5.545 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 2.811 | |
Cholinesterase | Equus caballus (horse) | 5.55 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 1.701 | |
Lanosterol 14-alpha demethylase | Homo sapiens (human) | 0.2 | |
Indoleamine 2,3-dioxygenase 2 | Mus musculus (house mouse) | 6.7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yamaguchi, H | 1 |
Goad, LJ; Parkin, ET; Rolph, CE | 1 |
De Logu, A; Diana, G; Fadda, AM; Pellerano, ML; Schivo, ML | 1 |
Carmona-Ribeiro, AM; Pacheco, LF | 1 |
Kunastitchai, S; Müller, BW; Panyarachun, B; Sarisuta, N | 1 |
Kunastitchai, S; Müller, BW; Pichert, L; Sarisuta, N | 1 |
Carmona-Ribeiro, AM | 1 |
7 other study(ies) available for phosphatidylcholines and miconazole
Article | Year |
---|---|
Protection by unsaturated lecithin against the imidazole antimycotics, clotrimazole and miconazole.
Topics: Absorption; Candida albicans; Clotrimazole; Imidazoles; Miconazole; Microbial Sensitivity Tests; Phosphatidylcholines; Solubility | 1978 |
Effects of sterol biosynthesis inhibitors on phosphatidylcholine biosynthesis in Apium graveolens.
Topics: Cells, Cultured; Choline-Phosphate Cytidylyltransferase; Fungicides, Industrial; Miconazole; Microsomes; Morpholines; Naphthalenes; Nucleotidyltransferases; Phosphatidylcholines; Sterols; Terbinafine; Vegetables | 1994 |
Prevention by L-alpha-phosphatidylcholine of antifungal activity in vitro of liposome-encapsulated imidazoles determined by using time-killing curves.
Topics: Antifungal Agents; Cholesterol; Ketoconazole; Liposomes; Miconazole; Phosphatidylcholines | 2000 |
Effects of synthetic lipids on solubilization and colloid stability of hydrophobic drugs.
Topics: Bromides; Colloids; Drug Delivery Systems; Light; Lipid Bilayers; Lipids; Miconazole; Organophosphates; Phosphatidylcholines; Quaternary Ammonium Compounds; Scattering, Radiation; Sodium; Temperature; Time Factors | 2003 |
Physical and chemical stability of miconazole liposomes prepared by supercritical aerosol solvent extraction system (ASES) process.
Topics: Aerosols; Chemistry, Pharmaceutical; Cholesterol; Drug Stability; Drug Storage; Humans; Hydrogen-Ion Concentration; Hydrolysis; Liposomes; Lymphocytes; Miconazole; Particle Size; Phosphatidylcholines; Poloxamer; Pressure; Solvents; Temperature | 2007 |
Drug solubility in phospholipid carrier as a predictive parameter for drug recovery in microparticles produced by the aerosol solvent extraction system (ASES) process.
Topics: Aerosols; Betamethasone Valerate; Calorimetry, Differential Scanning; Chloramphenicol; Cholesterol; Diazepam; Drug Carriers; Forecasting; Hot Temperature; Miconazole; Microscopy, Electron, Scanning; Microspheres; Particle Size; Phosphatidylcholines; Phospholipids; Solubility; Solvents; X-Ray Diffraction | 2007 |
Preparation and characterization of biomimetic nanoparticles for drug delivery.
Topics: Biomimetic Materials; Drug Delivery Systems; Lipid Bilayers; Miconazole; Nanoparticles; Phosphatidylcholines; Quaternary Ammonium Compounds; Silicon Dioxide | 2012 |